| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
2
1
4
3
3
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
1 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 5.96 | 4.06 | 1.9 |
| Stocks | 46.57 | 0.0 | 46.57 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.0 | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 51.53 | 0.0 | 51.53 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| DexCom, Inc. | DXCM | 24.36 | 4.92 |
| Strides Arcolab Ltd. | STAR | --- | 4.6 |
| Alere Inc | ALR | 40.11 | 4.57 |
| Oxford Nanopore Technologies Ltd. (United Kingdom) | --- | --- | 4.53 |
| Myriad Genetics, Inc. | MYGN | -0.04 | 4.38 |
| Insulet Corporation | PODD | 15.79 | 4.21 |
| Incyte Corp Ltd | INCY | 29.56 | 4.09 |
| Sirona Dental Systems, Inc. | SIRO | 13.16 | 3.78 |
| Lupin Ltd | LUPIN | --- | 3.72 |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | --- | 3.63 |
